Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321

Watchlist Manager
Shenzhen Chipscreen Biosciences Co Ltd Logo
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Watchlist
Price: 29.01 CNY -0.21%
Market Cap: 11.8B CNY

Wall Street
Price Targets

Price Targets Summary
Shenzhen Chipscreen Biosciences Co Ltd

There are no price targets for Shenzhen Chipscreen Biosciences Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Shenzhen Chipscreen Biosciences Co Ltd Competitors:
Price Targets
LUPIN
Lupin Ltd
10% Upside
4506
Sumitomo Pharma Co Ltd
5% Downside
DPHARMA
Duopharma Biotech Bhd
36% Upside
000520
Samil Pharmaceutical Co Ltd
38% Upside
000999
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
34% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
23% Upside
1177
Sino Biopharmaceutical Ltd
51% Upside
3933
United Laboratories International Holdings Ltd
60% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Chipscreen Biosciences Co Ltd

For the last 7 years the compound annual growth rate for Shenzhen Chipscreen Biosciences Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 50%.

29%
Past Growth
50%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shenzhen Chipscreen Biosciences Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Shenzhen Chipscreen Biosciences Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Chipscreen Biosciences Co Ltd's stock price target?
Not Available

Shenzhen Chipscreen Biosciences Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Shenzhen Chipscreen Biosciences Co Ltd's Revenue forecast?
Projected CAGR
50%

For the last 7 years the compound annual growth rate for Shenzhen Chipscreen Biosciences Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 50%.

Back to Top